BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• The BH3 domain of Bcl-2 family proteins is crucial for initiating apoptosis by releasing cytochrome c.
• Understanding the precise mechanism of cytochrome c release is vital for developing targeted therapies.

Purpose of the Study:

• To investigate if a Bax-derived BH3 peptide can induce mitochondrial outer membrane permeabilization and cytochrome c release.
• To determine if this release occurs independently of the mitochondrial permeability transition pore.

Main Methods:

• Treatment of isolated mitochondria with varying concentrations of BH3 peptide.
• Assessing cytochrome c and adenylate kinase release.
• Monitoring mitochondrial membrane potential and swelling.
• Evaluating the effect of Bcl-2 and permeability transition pore inhibitors.

Main Results:

• BH3 peptide induced cell-type-selective cytochrome c release, dependent on endogenous Bax.
• Cytochrome c release was independent of mitochondrial swelling and inner membrane potential loss.
• Bcl-2 inhibited BH3 peptide-induced cytochrome c release, while permeability transition pore inhibitors had no effect.
• Mitochondria maintained membrane potential post-cytochrome c release due to ATP synthase reversal.

Conclusions:

• BH3 peptide facilitates cytochrome c release via a Bax-dependent mechanism.
• This process is distinct from the mitochondrial permeability transition pore.
• Bcl-2 acts as a regulator, inhibiting this specific pathway of cytochrome c release.